Business Unit Head of Oncology

Job description

Job Description Brief Description / Overall Purpose of Position: The Associate Director / Business Unit Head of Oncology provides overall business direction and leadership for the Oncology franchise in Indonesia. The role is accountable for franchise strategy, P&L delivery, portfolio growth, resource allocation, commercial execution, and people leadership. The role is enhanced to cover both Private Oncology business and Public Oncology Opportunity, ensuring business growth is pursued through strong cross-functional partnership with Market Access, Medical Affairs, Government Affairs, Regulatory, Finance, and Commercial Operations. (The role is expected to build a future-ready Oncology franchise while developing leadership agility that can be transferable to other therapeutic areas and future Organisation pipeline opportunities) Business Scope Private Oncology business and expanded Public Oncology Opportunity Key Roles & Responsibilities: A. Lead Oncology Franchise Strategy and P&L Own Oncology business strategy, annual operating plan, forecast, and delivery of committed business targets. Drive Oncology franchise growth across private and public market opportunities. Analyze market dynamics, customer needs, competitor activity, and patient access barriers to identify sustainable growth opportunities. Make resource allocation recommendations to optimize impact, ROI, and business sustainability. Ensure Oncology strategy is aligned with Indonesia business priorities and relevant regional/global franchise direction. B. Expand Public Oncology Opportunity as Part of M2 Business Scope Identify and prioritize public sector Oncology business opportunities in partnership with Market Access and enabling functions. Build the business case for public opportunity development, including commercial potential, patient impact, resource needs, and execution requirements. Integrate public opportunity plans into Oncology franchise planning and business review cadence. Partner with Market Access, Medical Affairs, Government Affairs, Finance, Regulatory, and Commercial Operations to enable access, reimbursement, formulary, and institutional pathways. Maintain clear role boundaries: BU Head owns business prioritization and commercial outcomes; Market Access owns technical access strategy and execution. C. Drive Commercial Execution and Field Excellence Translate Oncology strategy into actionable marketing, customer engagement, and field implementation plans. Ensure alignment of salesforce and marketing activities with brand, portfolio, and customer strategy. Monitor implementation effectiveness and adjust plans based on market feedback, performance indicators, and customer insights. Drive disciplined business reviews and ensure follow-through on key actions and commitments. Ensure all commercial activities are conducted with high standards of ethics, compliance, and company policy. D. Lead Cross-Functional Oncology Governance Orchestrate cross-functional collaboration across Market Access, Medical Affairs, Government Affairs, Regulatory, Finance, Commercial Operations, and regional/global stakeholders. Facilitate alignment on key decisions, milestones, risks, and trade-offs for private and public Oncology opportunities. Escalate business-critical barriers and support rapid, disciplined decision-making. Create clear RACI and governance discipline between Oncology BU and enabling functions. E. Build Talent, Capability, and Franchise Resilience Lead, coach, and develop Oncology team members to deliver strong performance and sustainable engagement. Build team capability in strategic account planning, public market understanding, customer engagement, access awareness, and execution excellence. Conduct regular performance, development, and succession discussions. Create a learning culture that supports adaptability, feedback, experimentation, and resilience. Develop future-ready talent who can support Oncology growth and broader company pipeline opportunities. F. Strengthen External and Internal Stakeholder Engagement Build effective relationships with KOLs, key customers, public sector decision makers, and institutional stakeholders. Partner with Market Access and Government Affairs for payer, reimbursement, formulary, and policy-related external engagement. Represent Oncology business perspective in internal leadership forums and selected external engagements. Communicate complex Oncology business, science, and access topics in a clear and business-relevant way. Key Working Relationships Internal Relationships Managing Director / Country Leadership Team Market Access Medical Affairs Regulatory Affairs Government Affairs / Policy Finance Commercial Operations / Business Effectiveness Human Resources Regional / Global Oncology Franchise External Relationships Key Opinion Leaders Oncologists and relevant healthcare professionals Public sector decision makers Hospitals and healthcare institutions Payer / reimbursement stakeholders, in partnership with Market Access Distributors / strategic partners as applicable Qualifications, Experience & Technical Capabilities Bachelor degree in Pharmacy, Medicine, Life Sciences, Business, Marketing, or relevant field; advanced degree is an advantage. Minimum 5–7 years of commercial leadership experience in pharmaceutical / healthcare industry, preferably with specialty care, oncology, or complex portfolio experience. Proven ability to lead Sales and Marketing teams and deliver business performance through others. Strong understanding of Oncology market dynamics, customer engagement, portfolio management, and patient access barriers. Experience working with cross-functional teams including Market Access, Medical Affairs, Regulatory, Finance, Government Affairs, and regional/global stakeholders. Working knowledge of public healthcare environment, reimbursement dynamics, and patient access pathways is preferred; technical access ownership remains with Market Access function. Demonstrated ability to manage budget, forecast, resource allocation, and business trade-offs. Leadership & Soft Skills Required for Future Organisation Franchise Agility Leadership / Soft Skill: Expected Behaviour Enterprise Mindset: Thinks beyond Oncology and makes decisions that optimize value for the organization, patients, and enterprise priorities. Strategic Agility: Adapts quickly to changing market, access, policy, competitor, and pipeline dynamics; able to learn and lead new therapeutic areas in the future. Learning Agility and Growth Mindset: Learns new science, market models, and customer ecosystems quickly; seeks feedback and continuously improves. Systems Thinking: Understands the full healthcare ecosystem including patients, HCPs, hospitals, payers, government, distributors, advocacy groups, and internal enabling functions. Innovation Leadership: Challenges traditional go-to-market approaches and encourages experimentation, digital/data-driven thinking, and new partnership models. Influence Without Authority: Aligns cross-functional and regional stakeholders without relying only on direct reporting lines. Executive Communication: Simplifies complex business, science, and access topics into clear options, recommendations, and decisions for senior leaders. Resilience and Ambiguity Tolerance: Stays effective under uncertainty, access barriers, policy shifts, competitive pressure, and organizational change. Courage and Candor: Speaks up, challenges assumptions constructively, escalates risks, and makes disciplined decisions with ethics and integrity. Talent Builder: Develops a strong, adaptable team and builds succession capability for broader franchise and therapeutic area leadership roles. Core Competencies • Customer and Market Insights • Strategic Business Management • Commercial Execution Excellence • P&L and Budget Management • Portfolio and Lifecycle Management • Market Access Awareness • Cross-Functional Collaboration • Regulatory and Compliance Knowle